Early stage pre-clinical results have yielded positive screening results from in vitro studies of Photosoft on the inhibition of multiple strains of viruses and bacteria. The tests were undertaken by Invion’s research partners, including the Australian Centre for Antimicrobial Resistance Ecology (ACARE), which is part of the University of Adelaide, and Viroclinics-DDL (Cerba Research).For more information, you can search through Invion’s ASX announcements by clicking here.
Invion
For more information, you can search through Invion’s ASX announcements by clicking here.